Introduction
Preeclampsia is usually identified during prenatal care through a combination of blood pressure measurements, urine testing, laboratory studies, and clinical assessment. It is a pregnancy-specific disorder in which abnormal placental development and maternal blood vessel dysfunction lead to high blood pressure and signs of organ involvement, most often after 20 weeks of gestation. Because it can worsen quickly and affect both the pregnant person and the fetus, accurate diagnosis is important for deciding when closer monitoring, medication, hospitalization, or delivery may be needed.
Diagnosis is not based on symptoms alone. Some people develop obvious warning signs, while others are first recognized because routine prenatal blood pressure checks or urine tests reveal abnormalities. Clinicians look for a pattern that suggests impaired maternal endothelial function and reduced placental perfusion, which can affect the kidneys, liver, brain, and other organs. The diagnostic process is designed to confirm that elevated blood pressure is part of this pregnancy-related syndrome rather than a chronic or unrelated condition.
Recognizing Possible Signs of the Condition
Preeclampsia may be suspected when a pregnant patient develops new hypertension after mid-pregnancy, especially if protein appears in the urine or if there are signs that another organ system is being affected. Some patients have no symptoms at all, which is why routine screening is so important. In other cases, symptoms prompt an evaluation before a formal diagnosis is made.
Common warning features include persistent headaches, visual changes such as blurred vision or flashing lights, swelling that appears suddenly or becomes pronounced, pain in the upper right abdomen or under the ribs, shortness of breath, nausea or vomiting late in pregnancy, and a general sense of being unwell. These symptoms are not specific to preeclampsia, but they can reflect the effects of high blood pressure or vascular injury on the brain, liver, lungs, or kidneys.
Clinicians also pay attention to rapid weight gain, decreased urine output, and severe swelling of the face or hands, though swelling alone is not enough to diagnose the condition. In severe disease, signs may include very high blood pressure, altered reflexes, confusion, or reduced oxygenation. Fetal concerns such as decreased growth or abnormal fetal movement may also raise suspicion because preeclampsia can impair placental blood flow.
Medical History and Physical Examination
The diagnostic evaluation begins with a detailed medical history. A clinician will ask when symptoms began, whether blood pressure had been normal earlier in pregnancy, and whether there is any prior history of hypertension, kidney disease, autoimmune disease, diabetes, migraine, or prior preeclampsia. These factors matter because they can increase risk or complicate interpretation of findings. The clinician also asks about medications, multiple gestation, in vitro fertilization, and family history of hypertensive disorders in pregnancy.
During the physical examination, blood pressure is measured carefully, often more than once, using the correct cuff size and patient positioning. Diagnosis depends on documented hypertension rather than a single isolated reading in an uncontrolled setting. The examination may also include assessment of body weight, edema, reflexes, lung sounds, abdominal tenderness, and neurologic status. Although swelling is common in pregnancy, sudden or unusual edema may support further investigation.
Providers may ask about symptom severity and whether headaches respond to usual measures, whether visual symptoms are transient or persistent, and whether there is pain with breathing or lying flat. In severe cases, physical examination can reveal signs of fluid overload, increased blood pressure, or neurologic irritability. The obstetric evaluation also includes fetal assessment, because maternal vascular dysfunction can translate into reduced placental function and fetal growth restriction.
Diagnostic Tests Used for Preeclampsia
Several tests are used to confirm the diagnosis and assess severity. Blood pressure remains central, but laboratory studies and fetal evaluation help determine whether the condition is affecting organs beyond the vascular system.
Blood pressure measurement is the primary screening and diagnostic tool. Preeclampsia is generally considered when blood pressure reaches 140/90 mm Hg or higher after 20 weeks of gestation in a previously normotensive patient, with confirmation on repeat readings. Very high values, especially 160/110 mm Hg or above, suggest severe disease and require urgent attention.
Urine testing evaluates protein loss, which reflects kidney involvement from glomerular endothelial injury. Proteinuria can be identified with a dipstick in the office, but more precise methods are preferred for confirmation. A 24-hour urine collection measures total protein excretion over a full day. Alternatively, a spot urine protein-to-creatinine ratio can estimate whether protein excretion is high enough to meet diagnostic thresholds. Proteinuria is common in preeclampsia, though its absence does not exclude the condition if other organ dysfunction is present.
Laboratory blood tests are used to look for organ injury and to distinguish preeclampsia from other disorders. A complete blood count can reveal low platelets, which may indicate a more severe form of disease or a related syndrome such as HELLP. Liver function tests measure enzymes such as AST and ALT, which may rise if the liver is affected. Kidney function is assessed with serum creatinine and sometimes blood urea nitrogen. Elevated creatinine suggests renal impairment. Additional tests may include lactate dehydrogenase and bilirubin if hemolysis or more advanced disease is suspected.
Functional evaluation of coagulation and blood cell injury may be performed when clinicians worry about complications such as HELLP syndrome or disseminated intravascular coagulation. Peripheral blood smear, haptoglobin, and coagulation studies can help identify hemolysis or clotting abnormalities. These tests are not required in every case, but they become important when symptoms or basic labs suggest a systemic process rather than isolated hypertension.
Fetal ultrasound is a key imaging test because preeclampsia can impair placental blood delivery and slow fetal growth. Ultrasound can measure fetal size, estimate amniotic fluid volume, and evaluate placental appearance. If growth restriction is present, it supports the idea that placental dysfunction is affecting the pregnancy. Doppler studies of the umbilical artery or other fetal vessels may show increased resistance to blood flow, which can indicate placental insufficiency.
Fetal monitoring may include nonstress testing or a biophysical profile. These tests assess fetal heart rate patterns, movement, breathing motions, muscle tone, and amniotic fluid. They do not diagnose preeclampsia directly, but they help determine whether the fetus is being affected by the maternal condition and whether delivery might need to be considered sooner.
Tissue examination is not used routinely during diagnosis, but placental pathology after delivery may confirm features consistent with maternal vascular malperfusion. In difficult cases, examination of placental tissue can help explain fetal growth restriction, abruption, or recurrent pregnancy complications. It is more of a retrospective and explanatory tool than a frontline diagnostic test.
In selected situations, additional imaging or specialty testing may be used to evaluate complications. For example, brain imaging may be necessary if severe headache, seizures, confusion, or focal neurologic deficits raise concern for stroke, cerebral edema, or posterior reversible encephalopathy syndrome. Chest imaging may be used if shortness of breath suggests pulmonary edema or another cardiopulmonary issue.
Interpreting Diagnostic Results
Doctors interpret test results as part of a broader clinical pattern. The classic diagnosis of preeclampsia requires new-onset hypertension after 20 weeks with either proteinuria or evidence of organ dysfunction. Proteinuria is helpful, but it is not the only marker. A patient with hypertension and low platelets, elevated liver enzymes, worsening kidney function, pulmonary edema, or neurologic symptoms may still be diagnosed even if urine protein is not markedly elevated.
The severity of findings influences interpretation. Mild elevations in blood pressure with only small amounts of protein may suggest early or less severe disease, while very high blood pressure, rapidly worsening kidney function, abnormal liver enzymes, or neurologic symptoms point to higher risk. Clinicians also look for trends over time rather than a single abnormal value, because preeclampsia can progress.
In practice, the diagnosis is confirmed when the combination of history, blood pressure pattern, urine findings, and laboratory results fits the expected syndrome and no better explanation is found. The evaluation also helps determine whether the case is preeclampsia with severe features, which is clinically important because it changes monitoring intensity and may influence timing of delivery.
Conditions That May Need to Be Distinguished
Several other disorders can resemble preeclampsia, and clinicians must separate them because management differs. Chronic hypertension predating pregnancy can be mistaken for preeclampsia if blood pressure rises later in gestation. When baseline blood pressure is unknown, prior records and early prenatal readings are helpful.
Gestational hypertension is another important distinction. It involves elevated blood pressure after 20 weeks without proteinuria or organ dysfunction. Some patients initially have gestational hypertension and later develop preeclampsia, so continued monitoring is essential.
Kidney disease can cause proteinuria and elevated blood pressure independent of pregnancy. Autoimmune disorders such as lupus can also affect the kidneys and create overlapping findings. Liver diseases, viral hepatitis, gallbladder disease, and hemolytic disorders may explain elevated liver enzymes or abdominal pain. Thrombocytopenia from causes other than preeclampsia, such as immune thrombocytopenia or gestational thrombocytopenia, must also be considered.
In patients with headache or visual symptoms, migraine, severe anemia, intracranial pathology, or neurologic disease may be part of the differential diagnosis. HELLP syndrome is closely related to preeclampsia but is often treated as a severe variant characterized by hemolysis, elevated liver enzymes, and low platelets. Distinguishing among these conditions depends on the full clinical picture and targeted laboratory evaluation.
Factors That Influence Diagnosis
Several factors can make diagnosis easier or more complicated. Gestational age is central because preeclampsia is defined by new-onset disease after 20 weeks in most cases. If high blood pressure appears earlier, clinicians look carefully for chronic hypertension, renal disease, or another underlying condition.
Patient age, first pregnancy status, multiple gestation, obesity, diabetes, autoimmune disease, and a history of preeclampsia all raise the level of suspicion. These risk factors do not diagnose the condition, but they influence how aggressively clinicians monitor blood pressure, urine protein, and fetal growth.
Preexisting medical conditions can blur the picture. Someone with chronic hypertension may develop a superimposed preeclampsia, which is diagnosed when blood pressure worsens and new proteinuria or organ dysfunction appears. Underlying kidney disease can make proteinuria difficult to interpret, so clinicians rely more heavily on trends, laboratory abnormalities, and maternal symptoms.
Severity at presentation also shapes the diagnostic process. A patient with mild blood pressure elevation and no symptoms may undergo serial outpatient testing, whereas severe hypertension, neurologic symptoms, or abnormal labs may prompt hospital evaluation. Access to prior prenatal records matters as well, because a baseline blood pressure trend or earlier urine results can clarify whether the disorder is new or evolving.
Conclusion
Preeclampsia is diagnosed through a combination of careful clinical observation and targeted testing. Clinicians look for new-onset hypertension after 20 weeks of pregnancy and then determine whether proteinuria or other signs of organ involvement are present. Blood pressure checks, urine protein studies, blood tests for kidney, liver, and platelet abnormalities, and fetal assessment all contribute to the diagnosis.
Because the disorder can affect multiple organ systems and can progress quickly, diagnosis is not based on symptoms alone or on a single laboratory result. Medical professionals interpret findings in context, compare them with prior prenatal data, and rule out other conditions that can produce similar abnormalities. This structured evaluation allows preeclampsia to be identified accurately and helps guide monitoring and treatment decisions for both mother and fetus.